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The spread of microorganisms in hospitals is an important public health threat, and yet
few studies have assessed how human microbial communities (microbiota) evolve in the
hospital setting. Studies conducted so far have mainly focused on a limited number of
bacterial species, mostly pathogenic ones and primarily during outbreaks. We explored
the bacterial community diversity of the microbiota from oral and respiratory samples of
intubated patients hospitalized in the intensive care unit and we discuss the technical
challenges that may arise while using culture-independent approaches to study these
types of samples.
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SUBJECTS AND SAMPLE TYPES
Supraglottic secretions (SGS) and endotracheal aspirates (ETA)
were collected on a daily basis from five subjects over a 4-day
period following intubation (Supplementary Material). For each
subject, we also included a sample on day 5–11 depending on
availability. None of the patients developed ventilator-associated
pneumonia (VAP), so their oral/respiratory bacterial commu-
nities likely represent “healthy” microbiota of mechanically
ventilated patients.
SEQUENCE DATA PROCESSING
After pyrosequencing of 16S rDNA V1-3 amplicon libraries from
the reverse primer (Supplementary Material), a total of 383,302
sequence reads had an exact match to the barcode sequence.
Removal of sequence reads based on (1) the match to the 16S
rDNA sequence of the reverse primer, (2) length, (3) quality
score, (4) the presence of homopolymer runs and (5) ambigu-
ous bases, resulted in 375,612 (98%), 375,210 (99.8%), 266,338
(69.5%), 266,338 (69.5%), and 264,358 (69%) sequences, respec-
tively. The BLASTN-based OTU picking, performed as described
previously (Lazarevic et al., 2013a) using the Greengenes tax-
onomy (McDonald et al., 2012), further reduced the dataset to
217,531 sequences (56.8%) of which 209,477 derived from the 50
clinical (25 SGS and 25 ETA) samples and 8054 sequence reads
corresponded to 8 negative controls (reagents). After removal of
possibly contaminant 16S rDNA sequences (see below) the sam-
ple dataset was represented by 194,322 sequences. The number of
sequences per sample varied between 9 and 7665 (average 3886,
median 4500). The average number of sequences per individual
were 24,712 (median 22,763) and 14,153 (median 15,082) for SGS
and ETA, respectively.
MICROBIOTA PROFILES
The phyla Firmicutes, Proteobacteria, Bacteroidetes,
Fusobacteria, Tenericutes and Actinobacteria were highly
prevalent (42–50 positive samples) and corresponded on average
to >97% of the 16S rDNA sequences in both SGS and ETA
samples datasets. The less abundant phyla Spirochaetes, TM7 and
Synergistetes were also identified in both samples types (24–30
positive samples). Other phyla, SR1, Cyanobacteria, Thermi and
WPS-2 were found each in less than 5 samples at low proportion
(<0.2%). A total of 115 genera were identified in the dataset. At
the genus level, SGS and ETA microbiota showed high similarity
in terms of the prevalence (Pearson R = 0.884) and average
relative abundance (Pearson R = 0.854). Genera Streptococcus,
Neisseria, and Prevotella had the highest proportion in both
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samples types and represented together 56 and 57% of sequence
reads in SGS and ETA, respectively. In contrast, Mycobacterium,
the fourth most abundant genus in SGS (6.7%) and ETA (3.1%)
has been identified in saliva at very low levels (Lazarevic et al.,
2011). Interestingly, in a study which included intubated patients,
the genus Mycoplasma was found in bronchoalveolar lavages but
only in individuals who developed VAP or community associated
pneumonia (Bousbia et al., 2012). The other genus from the
phylum Tenericutes, Ureaplasma, was frequently identified as
dominant organism in tracheal aspirates from mechanically
ventilated preterm infants (Mourani et al., 2011).
We compared the SGS and ETA microbiota with those from
other body sites available from published studies. Both SGS and
ETA bacterial communities determined in our study clustered
together with salivary (Zaura et al., 2009; Lazarevic et al., 2010,
2013b; Segata et al., 2012; Ling et al., 2013) and throat (back wall
of oropharynx) microbiota (Segata et al., 2012), and were clearly
distinct from the skin microbiota (Ling et al., 2013) (unpub-
lished, MG-RAST ID 6526), nasopharyngeal microbiota (Bogaert
et al., 2011; Ling et al., 2013) and gut microbiota (Claesson et al.,
2009; Segata et al., 2012; Krych et al., 2013; Ling et al., 2013)
(Figure 1). This significantly supports the validity of our exper-
imental approach and shows that differences between anatomical
sites outweighed the methodological differences related to DNA
extraction, PCR amplification and bioinformatics analysis. Our
result is consistent with the recent metagenomic studies indi-
cating that the lower respiratory tract microbiota (including
trachea) originate mainly from the oral and upper respiratory
tract (including oropharynx) in healthy subjects and in disease
(Charlson et al., 2011; Cabrera-Rubio et al., 2012; Segata et al.,
2012). Similarly, culture-based studies showed that bacterial com-
munities of the pharyngeal and tracheal secretions are similar
(Pirracchio et al., 2009).
TECHNICAL CHALLENGES
Since many bacteria are not readily cultivable, the studies of bac-
terial communities using culture-independent methods provide a
benefit over the traditional approaches in which bacterial identi-
fication requires growth under laboratory conditions. However,
culture-free molecular methods introduce biases related to:
DNA extraction procedure, PCR amplification, sequencing plat-
form used, and bio-informatic analysis (Lazarevic et al., 2013a;
Lozupone et al., 2013). Below we discuss some of the challenges
in the culture-independent analysis of SGS and ETA related to the
physical and microbiological nature of these samples.
VISCOSITY OF SAMPLES
Because of the high viscosity observed in about 5% of ETA sam-
ples, we added dithiothreitol (DTT) in the lysis buffer for DNA
extraction. By dissolving mucus, DTT treatment liquefies samples
(Olsson et al., 1993) and allows for further and optimized sample
processing in a semi-automated workflow. DTT and other thiol-
reducing agents used to reduce in vitro viscosity of the mucin
(Sheffner, 1963) have the potential to inhibit the subsequent PCR
amplification (Deneer and Knight, 1994). We performed DNA
extraction with or without DTT addition for six ETA samples and
we found that 16S rDNA amplicon yields were higher when the
FIGURE 1 | Similarities between SGS, ETA, and bacterial communities
from other body parts. PCoA was based on Bray–Curtis similarity matrix
constructed using square-root transformed average relative abundance of
genera. The number following underscore corresponds to the number of
subjects analyzed. Saliva samples: SAL_192 (Segata et al., 2012), SAL_10
(Ling et al., 2013), SAL_18 (from children, before antibiotic treatment)
(Lazarevic et al., 2013b), SAL_18AB (from children, at the end of the
antibiotic treatment) (Lazarevic et al., 2013b), SAL_5 (three time points for
each subject) (Lazarevic et al., 2010), SAL_3 (Zaura et al., 2009). Throat
swab: THR_203 (Segata et al., 2012); Supraglottic secretions: SGS_5 (five
time points for each subject, this study); Endotracheal aspirate: ETA_5 (five
time points for each subject, this study). Skin samples: SKN_10 (Ling et al.,
2013), SKN_11 (MG-RAST ID 6526); Nasopharyngeal swabs: NPH_96
(Bogaert et al., 2011), NPH_10 (Ling et al., 2013). Stool samples: STL_224
(Segata et al., 2012), STL_10 (Ling et al., 2013), STL_16 (five time points for
each subject) (Krych et al., 2013), STL_4 (data designated V4-0.5) (Claesson
et al., 2009). The abundance of genera were taken directly from the tables
provided in corresponding publications, except for the SKN_11
(unpublished) for which the MG-RAST data were processed using the
bioinformatics pipeline as described in this paper.
extraction procedure included DTT-treatment (not presented).
Therefore, DTT may be systematically added to viscous samples
provided that it is efficiently washed away before the PCR step, as
evidenced in these conditions.
CO-EXTRACTION OF BACTERIAL AND HUMAN DNA
Real-time PCR revealed that the bacterial DNA concentration in
extracts varied from 0.1 to 4723 pg/µL with median values of
96.2 and 2.3 pg/µL for SGS and ETA, respectively. The yield of
humanDNAwas generally much higher (median 10.1 ng/uL) and
showed less variation in concentration (Figure 2A). Grice et al.
(2008) showed that a mixture of human and bacterial DNA in up
to a 100,000:1 mass ratio (100:1 cell ratio) did not significantly
alter 16S rDNA amplification. However, the presence of human
DNA is more critical when a whole genome shotgun sequencing
approach is to be used to study microbial communities because
many reads will derive from host DNA. To circumvent this poten-
tial limitation, a method for selective enrichment of microbial
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FIGURE 2 | Correlation between bacterial DNA yield and (A) human
DNA yield, (B) concentration of the 16S rDNA amplicons or (C)
percentage of putative contaminant 16S rDNA sequences. Bacterial and
human DNA concentration in purified extracts was determined by qPCR.
The yield of the 16S rDNA amplicon concentration was determined using
Bioanalyzer. Empty lozenges (in B) correspond to SGS samples from the
subject #5.
DNA from contaminating human host DNA has been devel-
oped (Feehery et al., 2013), but further progress is needed in
this area. Alternatively, host DNA sequences may be recognized
and removed by bio-informatic analysis (Schmieder and Edwards,
2011).
PCR INHIBITION
We observed that all of the five SGS samples from one patient
(#5) presumably contained PCR inhibitors. Figure 2B shows that
non-diluted SGS samples from this subject did not produce
measurable amounts of PCR products. A 100-fold sample dilu-
tion was required to obtain a visible band of the 16S rDNA
V1-3 amplicon upon electrophoresis. However, sample dilution
may not be optimal in cases where the bacterial concentration
is low, as it may reduce already low input DNA. The qPCR
analysis of the samples from patient #5 performed after serial
dilution did not reveal the inhibitory effect (not presented).
This is in line with evidence that PCR inhibition depends on
amplification conditions and the DNA polymerase being used
(Al-Soud and Rådström, 1998). Therefore, to reduce PCR inhi-
bition, it may be helpful to use genetically engineered DNA
polymerases highly tolerant to inhibition (Kermekchiev et al.,
2009).
CONTAMINANT DNA
Reagents used for DNA extraction and PCR may contain bacte-
rial DNA which is overruled by DNA from high-density samples.
However, sequence reads derived from samples with low DNA
concentration may largely originate from exogenous DNA con-
tamination.
We included in the pyrosequencing run the PCR ampli-
fication products obtained using eight negative controls. Any
operational taxonomic unit (OTU) that had greater average
relative abundance in negative controls than in clinical sam-
ples was considered as contaminant. The proportion of puta-
tive contaminant 16S rDNA sequences was inversely correlated
with bacterial DNA concentration in DNA extracts (Spearman
r = −0.850) (Figure 2C). Most contaminating OTUs (93/127)
were assigned to Proteobacteria, already identified before as
common reagent contaminants (Tanner et al., 1998; Biesbroek
et al., 2012; Willner et al., 2012). The sequence reads assigned
to the putative contaminating OTUs represented 7.2% of the
reads in the sample dataset. Processing of the sequence datasets
using a minimum identity threshold of 99% and the reference
OTU database pre-clustered at 99% resulted in only slightly
higher proportion (8%) of putative contaminating sequences.
However, distinction between putative contaminants and “true”
sequences will remain an important variable in metagenomic
approaches.
LOW DNA YIELD
It remains unclear whether prophylactic chlorhexidine oral rinse,
given to all patients in our study, decreases total bacterial load
in the trachea as it has been the case with saliva (Veksler et al.,
1991). 16S rDNA amplicon libraries deriving from the sam-
ples with very low bacterial load resulted in a low number of
sequence reads. DNA extraction using larger sample volume
(if available) and/or concentration of bacteria by centrifugation
may provide a solution. Performing additional PCR cycles in
order to increase the amplicon yield has been shown to intro-
duce amplification biases in salivary samples (Lazarevic et al.,
2012). Another strategy to cope with low DNA concentra-
tion is the use of multiple displacement amplification (MDA)
prior to 16S rDNA amplification (Pragman et al., 2012), but
MDA may also introduce a representational bias (Marine et al.,
2014).
OUTLOOK
In this pilot study, involving a small number of intubated
patients, we pointed to some common issues that may arise when
analysing their oropharyngeal and respiratory-tract microbiota.
We provided a preliminary characterization of the microbiota
associated with these specific sample types that have been only
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weakly (ETA) or not at all (SGS) studied so far using culture-
independent methods. The analysis of larger cohorts of intu-
bated patients with a longer follow-up period may allow to
(1) answer whether the oropharyngeal and respiratory micro-
biota from different patients converge to one or several dis-
tinct states during hospitalization and to (2) link microbiome
structure to the development of VAP which occurs in up to
30% of patients receiving mechanical ventilation (Morrow et al.,
2010).
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